(Q48607617)

13 February 2018

title

CSF hypocretin-1 levels in schizophrenics and controls: relationship to sleep architecture. (English)

1 reference

13 February 2018

0 references

3

Emmanuel Mignot

1 reference

13 February 2018

2

Beth Ripley

1 reference

13 February 2018

author name string

Seiji Nishino

series ordinal

1

1 reference

13 February 2018

Kathleen L Benson

series ordinal

4

1 reference

13 February 2018

Vincent P Zarcone

series ordinal

5

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 May 2002

1 reference

13 February 2018

published in

Psychiatry Research

1 reference

13 February 2018

volume

110

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

1-7

1 reference

13 February 2018

CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

Evidence for the Role of Serotonin in the Regulation of Slow Wave Sleep in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

Stage 4 sleep in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

UNUSUALLY HIGH DREAM TIME IN A HALLUCINATING PATIENT

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

Orexinergic innervation of POMC-containing neurons in the rat arcuate nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

Effects of orexins on the hypothalamic-pituitary-adrenal system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

Sleep disturbance in acute schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

Centrally administered orexin/hypocretin activates HPA axis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

Cerebrospinal fluid prostaglandins and corticotropin releasing factor in schizophrenics and controls: relationship to sleep architecture

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

Hypocretin (orexin) deficiency in human narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

Sleep disturbance in schizophrenia. A revisit

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

CSF hypocretin/orexin levels in narcolepsy and other neurological conditions.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

CSF corticotropin-releasing hormone in depressed patients and normal control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

The dopamine hypothesis of schizophrenia: focus on the dopamine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

Research diagnostic criteria: rationale and reliability

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

All-night sleep studies of acute schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

Cholinergic hyperactivity and negative schizophrenic symptoms. A model of cholinergic/dopaminergic interactions in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

Relationship between DST nonsuppression and shortened REM latency in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

Dexamethasone suppression test in schizophrenia: Relationship to symptomatology, ventricular enlargement, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

Sleep Stage Deficits in Chronic Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

Abnormal rapid eye movement latencies in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2802%2900032-X

7 January 2021

10.1016/S0165-1781(02)00032-X

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018